CHEN JESSE 4

4 · AXT INC · Filed Jun 5, 2026

AI-generated summary of this filing

Updated Jun 5, 2026

AXT (AXTI) Director Jesse Chen Sells Shares, Receives Equity Award

What Happened

Jesse Chen, a director of AXT Inc. (AXTI), sold a total of 10,133 shares in open-market dispositions on June 3–4, 2026 for combined proceeds of approximately $1,109,514. The sales were reported as: 4,000 shares on 2026-06-03 at a weighted average price of $111.36 (proceeds $445,440) and 6,133 shares on 2026-06-04 at a weighted average price of $108.28 (proceeds $664,074).
On 2026-06-04 Chen was also granted 754 shares as an annual equity award (calculated using the June 4, 2026 closing price of $105.99, value ≈ $79,916); the award vests on May 14, 2027. Sales (S) are dispositions; the award (A) is a grant.

Key Details

Transaction dates and prices:
- 2026-06-03: Sold 4,000 shares, weighted avg $111.36 (per-footnote range $106.68–$114.36), proceeds $445,440. (Footnote F1)
- 2026-06-04: Sold 6,133 shares, weighted avg $108.28 (per-footnote range $105.32–$112.26), proceeds $664,074. (Footnote F2)
- 2026-06-04: Award of 754 shares valued at $105.99/share (closing price) and vesting 2027-05-14. (Footnote F3; grant value ≈ $79,916)
Shares owned after transaction: Not specified in the provided excerpt of the filing — see the full Form 4 for post-transaction holdings.
Footnotes: Weighted-average prices reported; per-trade price breakdown available upon SEC/issuer/stockholder request (F1, F2). Grant value and vesting date provided (F3).
Filing timeliness: Form 4 filed 2026-06-05 for transactions on 6/3–6/4 — appears timely (Form 4 must generally be filed within two business days).

Context

Sales by directors can be routine (diversification, liquidity, tax planning) and do not by themselves signal company performance; purchases typically carry more direct bullish inference.
The 754-share award is an unvested, time-based grant scheduled to vest 5/14/2027 — not an immediate increase in tradable shares.
No indication in the provided data of a 10% owner transaction, 10b5-1 plan, or late filing. For full details (exact post-trade holdings and per-trade sale prices), consult the complete Form 4 filing (Accession: 0001437749-26-019750).

Form 4

Period: 2026-06-03

Director

Transactions

Footnotes (3)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.68 to $114.36,inclusive. Upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate transaction.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.32 to $112.26,inclusive. Upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate transaction.
[F3]Represents an annual equity grant of common stock calculated based upon $105.99, which was the closing price of the Issuer's common stock on June 4, 2026 (the "Grant Date"), and vests on May 14, 2027.

Signature

/s/ Jeff Sensiba, Attorney-in-Fact|2026-06-05

1 file